Business Wire (September 14, 2004)
Permanent Link:
http://vlex.com/vid/possis-yearly-u-angiojet-versus-prior-55531982
Id. vLex: VLEX-55531982
Acceda a este documento
y pruebe vLex GRATIS durante 3 días
Possis Medical, Inc. Reports Record Quarterly and Yearly Sales; U.S. AngioJet Revenue Up 27% versus Prior-Year Period.
MINNEAPOLIS -- Possis Medical, Inc. (Nasdaq:POSS) today reported record sales of $20.0 million for the fiscal quarter ended July 31, 2004, up 27 percent from the year-ago period. U.S. AngioJet(R) Rheolytic(TM) Thrombectomy System sales in the current quarter reached $19.7 million, up 27 percent from the year-ago period. For the year ended July 31, 2004, Possis reported record sales of $72.4 million, up 26 percent from prior year sales. Fiscal year 2004 U.S. AngioJet System sales were $70.9 million, up 26 percent versus the same period a year ago.
Net income per diluted...Try vLex for FREE for 3 days
Access legal information from United States including:
Try vLex without any commitment for 3 days and see why you need it.
3
days of Free Access
If you are already a vLex customer, Access Here